Attached files

file filename
EX-99.1 - PRESS RELEASE - ORTHOVITA INCdex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 13, 2011

 

 

ORTHOVITA, INC.

(Exact Name of Registrant Specified in Charter)

 

 

 

Pennsylvania   0-24517   23-2694857

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

77 Great Valley Parkway

Malvern, Pennsylvania

  19355
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone, including area code: (610) 640-1775

 

(Former Name and Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events

On April 13, 2011, Orthovita, Inc. announced the commercial launch of the Aliquot™ Directional Bone Tamp. A copy of the press release announcing this product launch is included as Exhibit 99.1 to this report.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.

 

Description

99.1   Press Release, dated April 13, 2011, issued by Orthovita, Inc.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ORTHOVITA, INC.
By:  

/s/ Christine J. Arasin

  Vice President and General Counsel

Dated: April 14, 2011